MITO-7: Weekly chemotherapy in ovarian cancer Last updated on Apr 21, 2024 Previous BEATcc: Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer Next NRG GY018: Pembrolizumab in Advanced Endometrial Cancer
